Pharma & Healthcare – the latest on the FDA and Xarelto, TPG and Chindex’s deal and more.
No FDA love for Xarelto in ACS patients by Carly Helfand Published on FiercePharma
Looks like the FDA has taken an advisory committee’s Xarelto concerns to heart. Following up on an overwhelming “no” vote from last month, the agency Friday issued Johnson & Johnson’s ($JNJ) Janssen unit complete response letters regarding use of the anticoagulant in acute coronary syndrome (ACS) patients…[ Read More ]
Fosun Pharma, TPG to take Chindex private in $369 mln deal by Reuters Published on Reuters
Chinese drugmaker Shanghai Fosun Pharmaceutical Group Co Ltd will become the largest shareholder in Chindex International Inc after it and private equity firm TPG said they would take the firm private in a $369 million deal… [ Read More ]
Pharma doing better than most industries, says EU Commission by Lyanne Taylor Published on Pharma Times
While it is not yet possible to assess the full impact of the latest economic crisis on industries in the European Union (EU), the pharmaceutical sector has fared better than others, says the European Commission… [ Read More ]